PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report)’s share price was down 6.1% on Monday . The stock traded as low as $0.7682 and last traded at $0.7736. Approximately 580,258 shares changed hands during mid-day trading, an increase of 6,471% from the average daily volume of 8,831 shares. The stock had previously closed at $0.8236.
PharmaCyte Biotech Stock Down 6.1%
The stock has a fifty day moving average of $0.91 and a two-hundred day moving average of $0.98.
PharmaCyte Biotech Company Profile
PharmaCyte Biotech, Inc is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
Further Reading
- Five stocks we like better than PharmaCyte Biotech
- Want to Profit on the Downtrend? Downtrends, Explained.
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- Are Penny Stocks a Good Fit for Your Portfolio?
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- 3 Monster Growth Stocks to Buy Now
- Go on a Shopping Spree With 3 Top Retail ETFs
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
